Understanding new genes using advanced computer techniques
Functional annotation of new genes aided by deep learning
['FUNDING_OTHER'] · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · NIH-10898043
This study is looking at new genes that might be linked to diseases like cancer and Alzheimer's, using advanced computer techniques to understand how these genes work and how they could help create better, personalized treatments for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-10898043 on ClinicalTrials.gov |
What this research studies
This research focuses on identifying and analyzing new genes that arise from various biological processes, particularly in relation to diseases like cancer and Alzheimer's. By utilizing deep learning methods, the project aims to systematically investigate the functions of these new genes and their potential as biomarkers and therapeutic targets. Patients may benefit from this research as it seeks to enhance precision medicine approaches, potentially leading to more effective treatments tailored to individual genetic profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with cancers associated with new gene mutations or those experiencing symptoms of Alzheimer's disease.
Not a fit: Patients with conditions unrelated to the new genes being studied or those who do not have genetic mutations may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of targeted therapies that improve treatment outcomes for patients with conditions like cancer and Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in targeting specific gene mutations in cancer treatment, indicating that this approach may lead to significant advancements.
Where this research is happening
HOUSTON, UNITED STATES
- UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KIM, PORA — UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
- Study coordinator: KIM, PORA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease